171 related articles for article (PubMed ID: 20530438)
41. Incremental impact of breast cancer SNP panel on risk classification in a screening population of white and African American women.
McCarthy AM; Armstrong K; Handorf E; Boghossian L; Jones M; Chen J; Demeter MB; McGuire E; Conant EF; Domchek SM
Breast Cancer Res Treat; 2013 Apr; 138(3):889-98. PubMed ID: 23474973
[TBL] [Abstract][Full Text] [Related]
42. Genetic variants in the mTOR pathway and interaction with body size and weight gain on breast cancer risk in African-American and European American women.
Cheng TY; Shankar J; Zirpoli G; Roberts MR; Hong CC; Bandera EV; Ambrosone CB; Yao S
Cancer Causes Control; 2016 Aug; 27(8):965-76. PubMed ID: 27314662
[TBL] [Abstract][Full Text] [Related]
43. CD44+/CD24- phenotype contributes to malignant relapse following surgical resection and chemotherapy in patients with invasive ductal carcinoma.
Lin Y; Zhong Y; Guan H; Zhang X; Sun Q
J Exp Clin Cancer Res; 2012 Jul; 31(1):59. PubMed ID: 22762532
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan.
Hiscox S; Baruha B; Smith C; Bellerby R; Goddard L; Jordan N; Poghosyan Z; Nicholson RI; Barrett-Lee P; Gee J
BMC Cancer; 2012 Oct; 12():458. PubMed ID: 23039365
[TBL] [Abstract][Full Text] [Related]
45. A review of the racial heterogeneity of breast cancer stem cells.
Gyan E; Owiredu WKBA; Fondjo LA; Jackson AM; Green AR; Rahman GA
Gene; 2021 Sep; 796-797():145805. PubMed ID: 34197949
[TBL] [Abstract][Full Text] [Related]
46. Does race predict survival for women with invasive breast cancer?
Walsh SM; Zabor EC; Stempel M; Morrow M; Gemignani ML
Cancer; 2019 Sep; 125(18):3139-3146. PubMed ID: 31206623
[TBL] [Abstract][Full Text] [Related]
47. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
48. Triple negative breast tumors in African-American and Hispanic/Latina women are high in CD44+, low in CD24+, and have loss of PTEN.
Wu Y; Sarkissyan M; Elshimali Y; Vadgama JV
PLoS One; 2013; 8(10):e78259. PubMed ID: 24167614
[TBL] [Abstract][Full Text] [Related]
49. Hyaluronan-CD44 interaction promotes c-Src-mediated twist signaling, microRNA-10b expression, and RhoA/RhoC up-regulation, leading to Rho-kinase-associated cytoskeleton activation and breast tumor cell invasion.
Bourguignon LY; Wong G; Earle C; Krueger K; Spevak CC
J Biol Chem; 2010 Nov; 285(47):36721-35. PubMed ID: 20843787
[TBL] [Abstract][Full Text] [Related]
50. CD44 gene polymorphisms on hepatocellular carcinoma susceptibility and clinicopathologic features.
Chou YE; Hsieh MJ; Chiou HL; Lee HL; Yang SF; Chen TY
Biomed Res Int; 2014; 2014():231474. PubMed ID: 24971320
[TBL] [Abstract][Full Text] [Related]
51. In situ identification of CD44+/CD24- cancer cells in primary human breast carcinomas.
Perrone G; Gaeta LM; Zagami M; Nasorri F; Coppola R; Borzomati D; Bartolozzi F; Altomare V; Trodella L; Tonini G; Santini D; Cavani A; Muda AO
PLoS One; 2012; 7(9):e43110. PubMed ID: 23028444
[TBL] [Abstract][Full Text] [Related]
52. Functional Genetic Variations at the microRNA Binding-Site in the CD44 Gene Are Associated with Risk of Colorectal Cancer in Chinese Populations.
Wu XM; Yang HG; Zheng BA; Cao HF; Hu ZM; Wu WD
PLoS One; 2015; 10(5):e0127557. PubMed ID: 26010608
[TBL] [Abstract][Full Text] [Related]
53. CD44 is prognostic for overall survival in the NCI randomized trial on breast conservation with 25 year follow-up.
Dan T; Hewitt SM; Ohri N; Ly D; Soule BP; Smith SL; Matsuda K; Council C; Shankavaram U; Lippman ME; Mitchell JB; Camphausen K; Simone NL
Breast Cancer Res Treat; 2014 Jan; 143(1):11-8. PubMed ID: 24276281
[TBL] [Abstract][Full Text] [Related]
54. Genetic association between CD44 polymorphisms and chronic hepatitis B virus infection in a Chinese Han population.
Li F; Shao Q; Ji D; Li B; Chen G
Int J Clin Exp Pathol; 2015; 8(9):11675-9. PubMed ID: 26617909
[TBL] [Abstract][Full Text] [Related]
55. Single-nucleotide polymorphisms in DNA bypass polymerase genes and association with breast cancer and breast cancer subtypes among African Americans and Whites.
Family L; Bensen JT; Troester MA; Wu MC; Anders CK; Olshan AF
Breast Cancer Res Treat; 2015 Jan; 149(1):181-90. PubMed ID: 25417172
[TBL] [Abstract][Full Text] [Related]
56. Associations between breast density and a panel of single nucleotide polymorphisms linked to breast cancer risk: a cohort study with digital mammography.
Keller BM; McCarthy AM; Chen J; Armstrong K; Conant EF; Domchek SM; Kontos D
BMC Cancer; 2015 Mar; 15():143. PubMed ID: 25881232
[TBL] [Abstract][Full Text] [Related]
57. Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Curtit E; Pivot X; Henriques J; Paget-Bailly S; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Kerbrat P; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Thomas G; Deleuze JF; Pauporté I; Romieu G; Cox DG
Breast Cancer Res; 2017 Aug; 19(1):98. PubMed ID: 28830573
[TBL] [Abstract][Full Text] [Related]
58. High-level expression of the CD44 variant sharing exon v10 in renal cancer.
Kan M; Aki M; Akiyama K; Naruo S; Kanayama H; Kagawa S
Jpn J Cancer Res; 1995 Sep; 86(9):847-53. PubMed ID: 7591962
[TBL] [Abstract][Full Text] [Related]
59. Functional polymorphisms in the CD44 gene and acute myeloid leukemia cancer risk in a Chinese population.
Wu H; Deng J; Zheng J; You Y; Li N; Li W; Wu D; Zhou Y
Mol Carcinog; 2015 Feb; 54(2):102-10. PubMed ID: 24038513
[TBL] [Abstract][Full Text] [Related]
60. CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells.
Boulbes DR; Chauhan GB; Jin Q; Bartholomeusz C; Esteva FJ
Breast Cancer Res Treat; 2015 Jun; 151(3):501-13. PubMed ID: 25971596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
